K. Srisutthisamphan

发表

Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus

A. Wanitchang, Janya Saenboonrueng, K. Srisutthisamphan, 2018, Archives of Virology.

Hsp90 interacts with multiple dengue virus 2 proteins

K. Srisutthisamphan, Atichat Kuadkitkan, Duncan R. Smith, 2018, Scientific Reports.

PEDV ORF3 Independently Regulates IκB Kinase β-Mediated NF-κB and IFN-β Promoter Activities

K. Srisutthisamphan, A. Jongkaewwattana, P. Jaru-Ampornpan, 2020, Pathogens.

Receptor binding domain proteins of SARS‐CoV‐2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern

S. Malaivijitnond, K. Srisutthisamphan, A. Jongkaewwattana, 2022, Journal of medical virology.

Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice

Anthony R. Jones, A. Wanitchang, Janya Saenboonrueng, 2022, Vaccines.

A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model

A. Wanitchang, Janya Saenboonrueng, K. Srisutthisamphan, 2021, Vaccines.

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques

S. Malaivijitnond, K. Srisutthisamphan, A. Jongkaewwattana, 2022, Frontiers in Plant Science.

Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses

A. Wanitchang, Janya Saenboonrueng, K. Srisutthisamphan, 2022, Viruses.

Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial

K. Srisutthisamphan, K. Chokephaibulkit, P. Licciardi, 2022, Journal of Infection.

Identification of Hsp90 as a species independent H5N1 avian influenza A virus PB2 interacting protein.

K. Srisutthisamphan, P. Auewarakul, O. Suptawiwat, 2015, Comparative immunology, microbiology and infectious diseases.

SARS-CoV-2 Delta (B.1.617.2) variant replicates and induces syncytia formation in human induced pluripotent stem cell-derived macrophages

A. Wanitchang, Janya Saenboonrueng, K. Srisutthisamphan, 2023, PeerJ.

A Single V672F Substitution in the Spike Protein of Field-Isolated PEDV Promotes Cell–Cell Fusion and Replication in VeroE6 Cells

A. Wanitchang, Janya Saenboonrueng, K. Srisutthisamphan, 2019, Viruses.

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

K. Srisutthisamphan, K. Chokephaibulkit, P. Licciardi, 2022, Human vaccines & immunotherapeutics.

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac and ChAdOx1 and BNT162b2 plus heterologous BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults.

K. Srisutthisamphan, K. Chokephaibulkit, P. Licciardi, 2022, medRxiv.

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine

S. Iamsirithaworn, A. Wanitchang, K. Srisutthisamphan, 2022, Vaccines.

Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations

K. Srisutthisamphan, K. Chokephaibulkit, P. Licciardi, 2023, Frontiers in Immunology.

Immunogenicity and adverse events of priming with inactivated whole SARS-CoV-2 vaccine (CoronaVac) followed by boosting the ChAdOx1 nCoV-19 vaccine

P. Thawong, A. Wanitchang, K. Srisutthisamphan, 2021, medRxiv.

Hsp90 interacts with multiple dengue virus 2 proteins

K. Srisutthisamphan, Atichat Kuadkitkan, Duncan R. Smith, 2018, Scientific Reports.

Characterization of influenza A virus pseudotyped with the spike protein of porcine epidemic diarrhea virus

A. Wanitchang, Janya Saenboonrueng, K. Srisutthisamphan, 2018, Archives of Virology.

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant

S. Malaivijitnond, S. Pichyangkul, K. Srisutthisamphan, 2023, Vaccine.

Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.

K. Srisutthisamphan, N. Hirankarn, K. Chokephaibulkit, 2023, Vaccine.

Impact of mAb-induced A475V substitution on viral fitness and antibody neutralization of SARS-CoV-2 omicron variants in the presence of monoclonal antibodies and human convalescent sera

T. Pisitkun, A. Wanitchang, K. Srisutthisamphan, 2023, Frontiers in immunology.

Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults

K. Srisutthisamphan, K. Chokephaibulkit, P. Assantachai, 2022, medRxiv.

In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion

A. Wanitchang, K. Srisutthisamphan, A. Jongkaewwattana, 2016, PloS one.

Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers

Songsak Tongchusak, T. Pisitkun, P. Opanasopit, 2023, Scientific reports.

Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study

K. Ruxrungtham, T. Puthanakit, K. Srisutthisamphan, 2024, Scientific reports.